The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Drug Discovery Today

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.drudis.2016.03.014PMID 27060373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidative Injury and Iron Redistribution Are Pathological Hallmarks of Marmoset Experimental Autoimmune Encephalomyelitis

  2017cited by this paper
• Survival and Functionality of Human Induced Pluripotent Stem Cell‐Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis

  2016cited by this paper
• A New Targeted Model of Experimental Autoimmune Encephalomyelitis in the Common Marmoset

  2016cited by this paper
• Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes

  2015cited by this paper
• An analysis of the attrition of drug candidates from four major pharmaceutical companies

  2015cited by this paper
• Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10–60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model

  2015cited by this paper
• Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis

  2015cited by this paper
• Lymphocyte Depletion After Alemtuzumab Induction Disrupts Intestinal Fungal Microbiota in Cynomolgus Monkeys

  2014cited by this paper
• Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy

  2014cited by this paper
• Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models

  2014cited by this paper
• Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging

  2014cited by this paper
• CD20+ B Cell Depletion Alters T Cell Homing

  2014cited by this paper
• Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapies.

  2014cited by this paper
• The formation of inflammatory demyelinated lesions in cerebral white matter

  2014cited by this paper
• Iron and neurodegeneration in the multiple sclerosis brain

  2013cited by this paper
• The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis

  2013cited by this paper
• Pathology and disease mechanisms in different stages of multiple sclerosis.

  2013cited by this paper
• The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model

  2013cited by this paper
• Unravelling the T‐cell‐mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34–56 peptide in incomplete adjuvant

  2012cited by this paper
• The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease.

  2012cited by this paper
• B-Cell Depletion Attenuates White and Gray Matter Pathology in Marmoset Experimental Autoimmune Encephalomyelitis

  2011cited by this paper
• Breaking Free of Sample Size Dogma to Perform Innovative Translational Research

  2011cited by this paper
• Discrepant Effects of Human Interferon-gamma on Clinical and Immunological Disease Parameters in a Novel Marmoset Model for Multiple Sclerosis

  2011cited by this paper
• Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis

  2010cited by this paper
• T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

  2010cited by this paper
• Late B Cell Depletion with a Human Anti-Human CD20 IgG1κ Monoclonal Antibody Halts the Development of Experimental Autoimmune Encephalomyelitis in Marmosets

  2010cited by this paper
• Human neural stem cells ameliorate autoimmune encephalomyelitis in non‐human primates

  2009cited by this paper
• Web-accessible digital brain atlas of the common marmoset (Callithrix jacchus).

  2009cited by this paper
• Grey matter pathology in multiple sclerosis.

  2008cited by this paper
• Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34–56-Specific Cytotoxic T Cells1

  2008cited by this paper
• Interferon-beta responders and non-responders. A biological approach

  2008cited by this paper
• Diffuse cortical atrophy in a marmoset model of multiple sclerosis.

  2008cited by this paper
• Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

  2006cited by this paper
• Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis

  2006cited by this paper
• The value of animal models for drug development in multiple sclerosis.

  2006cited by this paper
• Differential Macrophage/Microglia Activation in Neocortical EAE Lesions in the Marmoset Monkey

  2006cited by this paper
• Grey Matter Pathology in Multiple Sclerosis

  2005cited by this paper
• Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.

  2005cited by this paper
• Of Mice and Not Men: Differences between Mouse and Human Immunology

  2004cited by this paper
• A controlled trial of natalizumab for relapsing multiple sclerosis.

  2003cited by this paper
• Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients

  2003cited by this paper
• An Epstein-Barr-related herpesvirus from marmoset lymphomas.

  2001cited by this paper
• TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study

  1999cited by this paper
• TNF neutralization in MS

  1999cited by this paper
• Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus).

  1998cited by this paper
• Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma.

  1997cited by this paper
• Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

  1992cited by this paper
• Anti—tumor necrosis factor therapy abrogates autoimmune demyelination

  1991cited by this paper
• Perspectives in iron metabolism.

  1982cited by this paper
• Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

  1971cited by this paper

• A New Perspective on Mechanisms of Neurodegeneration in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: the Early and Critical Role of Platelets in Neuro/Axonal Loss

  2025cites this paper
• Active Induction of a Multiple Sclerosis-Like Disease in Common Laboratory Mouse Strains.

  2024cites this paper
• The cerebrospinal fluid immune cell landscape in animal models of multiple sclerosis

  2023cites this paper
• Cerebellar pathology in multiple sclerosis and experimental autoimmune encephalomyelitis: current status and future directions

  2023cites this paper
• In vivo MRI is sensitive to remyelination in a nonhuman primate model of multiple sclerosis

  2023cites this paper
• Biologically Excretable Aggregation‐Induced Emission Dots for Visualizing Through the Marmosets Intravitally: Horizons in Future Clinical Nanomedicine

  2021cites this paper
• In Vivo MRI of Endogenous Remyelination in a Nonhuman Primate Model of Multiple Sclerosis

  2021cites this paper
• Marmosets: Welfare, Ethical Use, and IACUC/Regulatory Considerations.

  2021cites this paper
• Genetically modified macrophages accelerate myelin repair

  2020cites this paper
• An exploratory rehearsal on AIE dots assisted NIR-II fluorescence non-human primates imaging

  2020cites this paper
• A Tolerogenic Role of Cathepsin G in a Primate Model of Multiple Sclerosis: Abrogation by Epstein–Barr Virus Infection

  2020cites this paper
• Novel Imaging Technology and Procedures for Studying Brain Function in Preadolescent Awake Marmosets.

  2020cites this paper
• A Tolerogenic Role of Cathepsin G in a Primate Model of Multiple Sclerosis: Abrogation by Epstein-Barr Virus Infection.

  2020cites this paper
• Biologically excretable AIE dots for visualizing through the marmosets intravitally: horizons in future clinical nanomedicine

  2020cites this paper
• The Use of the Marmoset in Toxicity Testing and Nonclinical Safety Assessment Studies

  2019cites this paper
• Experimental models of demyelination and remyelination☆

  2019cites this paper
• Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery

  2018cites this paper
• Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey

  2017cites this paper
• Modelos experimentales de desmielinización-remielinización

  2017cites this paper
• Translational multiple sclerosis research in primates

  2017cites this paper
• Analysis of the cross-talk of Epstein–Barr virus-infected B cells with T cells in the marmoset

  2017cites this paper
• A nociceptive stress model of adolescent physical abuse induces contextual fear and cingulate nociceptive neuroplasticities

  2017cites this paper
• Translational multiple sclerosis research in primates: Mind the gap

  2017cites this paper
• Translational multiple sclerosis research in primates

  2017cites this paper
• Anatomical and functional neuroimaging in awake, behaving marmosets

  2017cites this paper
• Primate autoimmune disease models; lost for translation?

  2016cites this paper
• Primate autoimmune disease models; lost for translation?

  2016cites this paper
• Translational multiple sclerosis research in primates

  year unknowncites this paper